Personalization of clopidogrel therapy based on genetic polymorphism analysis: clinical implications
American Journal of Translational Research · 2024 · 16 (10) · 5708-5717
DOI: 10.62347/ewuh3396 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Translational Research, 2024. Verfasst von Shixiong Chen und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Wuhu Hospital Affiliated to East China Normal University Wuhu 241000, Anhui, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacy, Wuhu Hospital Affiliated to East China Normal University Wuhu 241000, Anhui, China.
- Drug Research and Development Center, School of Pharmacy, Wannan Medical College Wuhu 241000, Anhui, China.
- Department of Oncology, Wuhu Hospital Affiliated to East China Normal University Wuhu 241000, Anhui, China.
Zitieren
APA
Chen, S., Yuan, P., Liu, F., & Zhang, S. (2024). Personalization of clopidogrel therapy based on genetic polymorphism analysis: clinical implications. American Journal of Translational Research, 16(10), 5708-5717. https://doi.org/10.62347/ewuh3396
Vancouver
Chen S, Yuan P, Liu F, Zhang S. Personalization of clopidogrel therapy based on genetic polymorphism analysis: clinical implications. American Journal of Translational Research. 2024;16(10):5708-5717. doi:10.62347/ewuh3396
BibTeX
@article{Chen2024,
author = {Chen, Shixiong and Yuan, Pingchuan and Liu, Fei and Zhang, Shaonan},
title = {Personalization of clopidogrel therapy based on genetic polymorphism analysis: clinical implications},
journal = {American Journal of Translational Research},
year = {2024},
volume = {16},
number = {10},
pages = {5708--5717},
doi = {10.62347/ewuh3396}
}
EUVIMED